• Je něco špatně v tomto záznamu ?

A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity

A. Ligasová, D. Strunin, D. Friedecký, T. Adam, K. Koberna,

. 2015 ; 10 (2) : e0117459. [pub] 20150211

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16010561

2'-Deoxy-5-ethynyluridine (EdU) has been previously shown to be a cell poison whose toxicity depends on the particular cell line. The reason is not known. Our data indicates that different efficiency of EdU incorporation plays an important role. The EdU-mediated toxicity was elevated by the inhibition of 2'-deoxythymidine 5'-monophosphate synthesis. EdU incorporation resulted in abnormalities of the cell cycle including the slowdown of the S phase and a decrease in DNA synthesis. The slowdown but not the cessation of the first cell division after EdU administration was observed in all of the tested cell lines. In HeLa cells, a 10 μM EdU concentration led to the cell death in the 100% of cells probably due to the activation of an intra S phase checkpoint in the subsequent S phase. Our data also indicates that this EdU concentration induces interstrand DNA crosslinks in HeLa cells. We suppose that these crosslinks are the primary DNA damage resulting in cell death. According to our results, the EdU-mediated toxicity is further increased by the inhibition of thymidylate synthase by EdU itself at its higher concentrations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16010561
003      
CZ-PrNML
005      
20180426204711.0
007      
ta
008      
160408s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0117459 $2 doi
024    7_
$a 10.1371/journal.pone.0117459 $2 doi
035    __
$a (PubMed)25671308
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ligasová, Anna $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
245    12
$a A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity / $c A. Ligasová, D. Strunin, D. Friedecký, T. Adam, K. Koberna,
520    9_
$a 2'-Deoxy-5-ethynyluridine (EdU) has been previously shown to be a cell poison whose toxicity depends on the particular cell line. The reason is not known. Our data indicates that different efficiency of EdU incorporation plays an important role. The EdU-mediated toxicity was elevated by the inhibition of 2'-deoxythymidine 5'-monophosphate synthesis. EdU incorporation resulted in abnormalities of the cell cycle including the slowdown of the S phase and a decrease in DNA synthesis. The slowdown but not the cessation of the first cell division after EdU administration was observed in all of the tested cell lines. In HeLa cells, a 10 μM EdU concentration led to the cell death in the 100% of cells probably due to the activation of an intra S phase checkpoint in the subsequent S phase. Our data also indicates that this EdU concentration induces interstrand DNA crosslinks in HeLa cells. We suppose that these crosslinks are the primary DNA damage resulting in cell death. According to our results, the EdU-mediated toxicity is further increased by the inhibition of thymidylate synthase by EdU itself at its higher concentrations.
650    _2
$a buněčné linie $7 D002460
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a cytotoxiny $x metabolismus $x toxicita $7 D003603
650    _2
$a DNA $x biosyntéza $x genetika $x metabolismus $7 D004247
650    12
$a poškození DNA $7 D004249
650    _2
$a replikace DNA $x účinky léků $7 D004261
650    _2
$a deoxyuridin $x analogy a deriváty $x metabolismus $x toxicita $7 D003857
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a inhibitory enzymů $x metabolismus $x toxicita $7 D004791
650    _2
$a lidé $7 D006801
650    _2
$a intracelulární prostor $x účinky léků $x metabolismus $7 D042541
650    _2
$a S fáze $x účinky léků $7 D016196
650    _2
$a tetrahydrofoláty $x biosyntéza $7 D013763
650    _2
$a thymidin $x metabolismus $x farmakologie $7 D013936
650    _2
$a thymidinmonofosfát $x metabolismus $7 D013938
650    _2
$a thymidylátsynthasa $x antagonisté a inhibitory $7 D013940
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Strunin, Dmytro $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
700    1_
$a Friedecký, David $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
700    1_
$a Adam, Tomáš, $d 1965- $7 xx0054162 $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
700    1_
$a Koberna, Karel $u Institute of Molecular and Translational Medicine, Faculty of Medicine, Palacký University, Olomouc, 779 00, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 10, č. 2 (2015), s. e0117459
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25671308 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20160408 $b ABA008
991    __
$a 20180426204744 $b ABA008
999    __
$a ok $b bmc $g 1113990 $s 934929
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 10 $c 2 $d e0117459 $e 20150211 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20160408

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...